Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe

W Witte1, C Braulke, C Cuny

  • 1Robert Koch Institute, Wernigerode Branch, Burgstrasse 37, 38855 Wernigerode, Germany. wittew@rki.de

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) strains carrying Panton-Valentine leukocidin genes were identified in Germany. These MRSA strains showed specific genetic profiles and resistance to multiple antibiotics, including community-acquired MRSA.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) strains producing Panton-Valentine leukocidin (PVL) are of increasing concern, especially those emerging in community settings.
  • PVL is a toxin associated with severe staphylococcal infections, and its genetic determinant (lukS-lukF) is a key virulence factor.

Purpose of the Study:

  • To investigate German MRSA strains for the presence of the lukS-lukF genes encoding PVL.
  • To characterize MRSA strains positive for PVL genes regarding their molecular typing, resistance profiles, and SCCmec elements.

Main Methods:

  • Polymerase chain reaction (PCR) was used to detect the lukS-lukF determinant in MRSA strains.
  • Molecular typing included SmaI macrorestriction, spa sequencing, and multilocus sequence typing (MLST).
  • Resistance genes and SCCmec elements were also characterized by PCR.

Main Results:

  • Since late 2002, 28 MRSA infections in Germany were linked to PVL-producing strains (9 community-acquired, 19 nosocomial).
  • Twenty-seven of these isolates shared a common genomic profile: MLST type 80, spa type 44, and a SmaI pattern consistent with French/Swiss community-acquired MRSA.
  • These strains were resistant to oxacillin, ciprofloxacin, tetracycline (tetM), and fusidic acid (encoded by plasmid-located far-1 gene).

Conclusions:

  • PVL-producing MRSA strains, particularly MLST type 80, have emerged in Germany, causing both community and hospital-acquired infections.
  • These strains possess a distinct genetic background and a multi-drug resistance pattern, highlighting the need for surveillance.
  • One isolate represented a US-origin community MRSA (cMRSA) with MLST type 1.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...